Literature DB >> 22426901

Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.

V O Chan1, J P Das, J F Gerstenmaier, J Geoghegan, R G Gibney, C D Collins, S J Skehan, D E Malone.   

Abstract

PURPOSE: To compare the relative diagnostic performance of MDCT, PET/CT and Primovist-enhanced MRI (P-MRI) in the pre-resection work-up of colorectal cancer (CRC) liver metastases. METHOD AND MATERIALS: This was a retrospective study of consecutive referrals for CRC liver metastases. All patients had MDCT, PET/CT and P-MRI examinations within 3 months of each other. They were divided into 2 groups: resected and unresected. Patients in the resected group underwent liver resection within 3 months of the imaging studies. In the unresected group, patients were unresectable by imaging criteria or are awaiting surgery. Standard of reference (SOR) was intra-operative ultrasound findings and pathology for the resected group. Intermodality comparison was the SOR for the unresected group. Number of lesions identified by each imaging modality for each patient was recorded. Sensitivity (95% CI) and PPV were calculated for each imaging modality in the resected group.
RESULTS: There were 19 patients in the resected group and 11 patients in the unresected group. The sensitivity (96%) and PPV (0.91) of P-MRI were both superior to that of MDCT (P = 0.0009) and PET/CT (P = 0.0003). Intermodality comparison showed that P-MRI detected more lesions than MDCT and PET/CT.
CONCLUSION: The sensitivity and PPV of P-MRI was superior to that of MDCT and PET/CT. P-MRI probably has the most added value if used after MDCT and PET/CT in patients still considered eligible for liver resection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22426901     DOI: 10.1007/s11845-012-0805-x

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  102 in total

1.  Intraoperative ultrasonography versus helical computed tomography and computed tomography with arterioportography in diagnosing colorectal liver metastases: lesion-by-lesion analysis.

Authors:  J Schmidt; M Strotzer; S Fraunhofer; H Boedeker; H Zirngibl
Journal:  World J Surg       Date:  2000-01       Impact factor: 3.352

2.  Recurrence of colorectal tumors: PET evaluation.

Authors:  L G Strauss; J H Clorius; P Schlag; B Lehner; B Kimmig; R Engenhart; M Marin-Grez; F Helus; F Oberdorfer; P Schmidlin
Journal:  Radiology       Date:  1989-02       Impact factor: 11.105

3.  Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis.

Authors:  J Ward; K S Naik; J A Guthrie; D Wilson; P J Robinson
Journal:  Radiology       Date:  1999-02       Impact factor: 11.105

4.  Liver lesion detection, characterization, and effect on patient management: comparison of single-phase spiral CT and current MR techniques.

Authors:  R C Semelka; S Worawattanakul; N L Kelekis; G John; J T Woosley; M Graham; W G Cance
Journal:  J Magn Reson Imaging       Date:  1997 Nov-Dec       Impact factor: 4.813

5.  Hepatic resection for metastases from colorectal carcinoma--a survival analysis.

Authors:  G R Jatzko; P H Lisborg; H M Stettner; M H Klimpfinger
Journal:  Eur J Cancer       Date:  1995       Impact factor: 9.162

6.  Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T.

Authors:  W S Whitney; R J Herfkens; R B Jeffrey; C H McDonnell; K C Li; W J Van Dalsem; R N Low; I R Francis; J F Dabatin; G M Glazer
Journal:  Radiology       Date:  1993-12       Impact factor: 11.105

7.  Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT.

Authors:  Carlo Bartolozzi; Francescamaria Donati; Dania Cioni; Carlo Procacci; Giovanni Morana; Antonio Chiesa; Luigi Grazioli; Giorgio Cittadini; Giuseppe Cittadini; Andrea Giovagnoni; Giovanni Gandini; Jochen Maass; Riccardo Lencioni
Journal:  Eur Radiol       Date:  2003-08-09       Impact factor: 5.315

8.  Factors influencing the natural history of colorectal liver metastases.

Authors:  R Stangl; A Altendorf-Hofmann; R M Charnley; J Scheele
Journal:  Lancet       Date:  1994-06-04       Impact factor: 79.321

9.  Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT.

Authors:  Wolfgang Schima; Reinhold Függer; Ewald Schober; Claudia Oettl; Peter Wamser; Florian Grabenwöger; J Mark Ryan; Gottfried Novacek
Journal:  AJR Am J Roentgenol       Date:  2002-09       Impact factor: 3.959

10.  Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT.

Authors:  Stephan M Wildi; Christoph Gubler; Thomas Hany; Henrik Petrowsky; Pierre A Clavien; Wolfram Jochum; Tilman Gerlach; Michael Fried; Beat Mullhaupt
Journal:  J Clin Ultrasound       Date:  2008-01       Impact factor: 0.910

View more
  11 in total

Review 1.  Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: a systematic review and meta-analysis.

Authors:  Thomas D Vreugdenburg; Ning Ma; Joanna K Duncan; Dagmara Riitano; Alun L Cameron; Guy J Maddern
Journal:  Int J Colorectal Dis       Date:  2016-09-29       Impact factor: 2.571

2.  A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases.

Authors:  Valérie Vilgrain; Maxime Esvan; Maxime Ronot; Aurore Caumont-Prim; Christophe Aubé; Gilles Chatellier
Journal:  Eur Radiol       Date:  2016-02-16       Impact factor: 5.315

Review 3.  The role of gadoxetic acid as a paramagnetic contrast medium in the characterization and detection of focal liver lesions: a review.

Authors:  Renata Lilian Bormann; Eduardo Lima da Rocha; Marcelo Longo Kierzenbaum; Bruno Cheregati Pedrassa; Lucas Rios Torres; Giuseppe D'Ippolito
Journal:  Radiol Bras       Date:  2015 Jan-Feb

4.  Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging.

Authors:  Elmar M Merkle; Christoph J Zech; Carlo Bartolozzi; Mustafa R Bashir; Ahmed Ba-Ssalamah; Alexander Huppertz; Jeong Min Lee; Jens Ricke; Michiie Sakamoto; Claude B Sirlin; Sheng-Long Ye; Mengsu Zeng
Journal:  Eur Radiol       Date:  2015-06-13       Impact factor: 5.315

5.  Non-invasive quantitative imaging of hepatocellular carcinoma growth in mice by micro-CT using liver-targeted iodinated nano-emulsions.

Authors:  Nicolas Anton; Alexandru Parlog; Ghina Bou About; Mohamed F Attia; Marie Wattenhofer-Donzé; Hugues Jacobs; Isabelle Goncalves; Eric Robinet; Tania Sorg; Thierry F Vandamme
Journal:  Sci Rep       Date:  2017-10-24       Impact factor: 4.379

6.  Accuracy of [18F]FDG PET/MRI for the Detection of Liver Metastases.

Authors:  Karsten Beiderwellen; Llanos Geraldo; Verena Ruhlmann; Philipp Heusch; Benedikt Gomez; Felix Nensa; Lale Umutlu; Thomas C Lauenstein
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

Review 7.  Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.

Authors:  Yee Liang Thian; Angela M Riddell; Dow-Mu Koh
Journal:  Cancer Imaging       Date:  2013-12-30       Impact factor: 3.909

8.  Segmentation of hepatic vessels from MRI images for planning of electroporation-based treatments in the liver.

Authors:  Marija Marcan; Denis Pavliha; Maja Marolt Music; Igor Fuckan; Ratko Magjarevic; Damijan Miklavcic
Journal:  Radiol Oncol       Date:  2014-07-10       Impact factor: 2.991

9.  Does the Gadoxetic Acid-Enhanced Liver MRI Impact on the Treatment of Patients with Colorectal Cancer? Comparison Study with ¹⁸F-FDG PET/CT.

Authors:  Ji-Won Oh; Soon Nam Oh; Joon Il Choi; Moon Hyung Choi; Ie Ryung Yoo; Myung Ah Lee; Young-Kyung Yoo; Seong Taek Oh
Journal:  Biomed Res Int       Date:  2016-02-28       Impact factor: 3.411

10.  Arterial Phase with CAIPIRINHA-Dixon-TWIST (CDT)-Volume-Interpolated Breath-Hold Examination (VIBE) in Detecting Hepatic Metastases.

Authors:  Jinrong Qu; Shuai Han; Hongkai Zhang; Hui Liu; Zhaoqi Wang; Ihab R Kamel; Kiefer Berthold; Nickel Marcel Dominik; Jianwei Zhang; Shouning Zhang; Yafeng Dong; Lina Jiang; Cuicui Liu; Hailiang Li
Journal:  Transl Oncol       Date:  2016-12-07       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.